Blood Pressure Control in Hypertensive Patients in Irish Primary Care Practices

被引:6
作者
Buckley, Brendan [1 ]
Shanahan, Eamonn [2 ]
Colwell, Niall
Turgonyi, Eva [3 ]
Bramlage, Peter [4 ]
Perry, Ivan J. [5 ]
机构
[1] Natl Univ Ireland Univ Coll Cork, European Ctr Clin Trials Rare Dis, Cork, Ireland
[2] Farranfore Med Ctr, Farranfore, Co Kerry, Ireland
[3] Sanofi Aventis Ireland Ltd, Dublin, Ireland
[4] Inst Cardiovasc Pharmacol, Mahlow, Germany
[5] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland
关键词
II RECEPTOR ANTAGONISTS; PREVALENCE; MANAGEMENT; RECOMMENDATIONS; GUIDELINES; IRBESARTAN; PHYSICIAN; MORTALITY; EFFICACY; SOCIETY;
D O I
10.1111/j.1751-7176.2009.00151.x
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
In Ireland, cardiovascular disease is a major cause of death. However, blood pressure (BP) goal achievement is unsatisfactory. The authors aimed to document BP control and increase awareness. A total of 1534 patients were enrolled in the study, with a mean age of 64.7 +/- 11.9 years (53.8% women). Duration of hypertension was 8.7 +/- 7.7 years, and 14.6% had diabetes, 13.8% had coronary artery disease, and 40.5% were taking antihypertensive monotherapy. beta-Blockers (39.8%), angiotensin-converting enzyme inhibitors (32.2%), and angiotensin receptor blockers (22.0%) were prescribed most frequently. Mean BP was 136.0 +/- 6.1 mm Hg/89.5 +/- 5.0 mm Hg in nondiabetic patients (48.6% < 140/90 mm Hg) and 131.0 +/- 7.4 mm Hg/81.7 +/- 4.6 mm Hg in diabetic patients (16.7% < 130/80 mm Hg). Diet, exercise, and lifestyle modifications (63.5%) were frequently recommended. Increased patient awareness and compliance together with the adherence of physicians to current guidelines and greater willingness to take action in patients with uncontrolled hypertension should help in improving BP control and thus reduce cardiovascular risk.
引用
收藏
页码:432 / 440
页数:9
相关论文
共 27 条
[1]   Cardiovascular protection using beta-blockers - A critical review of the evidence [J].
Bangalore, Sripal ;
Messerli, Franz H. ;
Kostis, John B. ;
Pepine, Carl J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (07) :563-572
[2]   Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000 [J].
Bennett, K ;
Kabir, Z ;
Unal, B ;
Shelley, E ;
Critchley, J ;
Perry, I ;
Feely, J ;
Capewell, S .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2006, 60 (04) :322-327
[3]   Clinical practice and recent recommendations in hypertension management - reporting a gap in a global survey of 1259 primary care physicians in 17 countries [J].
Bramlage, Peter ;
Thoenes, Martin ;
Kirch, Wilhelm ;
Lenfant, Claude .
CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (04) :783-791
[4]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[5]  
Creagh D, 2002, Ir Med J, V95, P298
[6]  
FLANAGAN K, 2008, CLIN FOCUS, V8, P4
[7]   Antihypertensive medication use among US adults with hypertension [J].
Gu, QP ;
Paulose-Ram, R ;
Dillon, C ;
Burt, V .
CIRCULATION, 2006, 113 (02) :213-221
[8]   Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan, in mild-to-moderate hypertension [J].
Kassler-Taub, K ;
Littlejohn, T ;
Elliott, W ;
Ruddy, T ;
Adler, E .
AMERICAN JOURNAL OF HYPERTENSION, 1998, 11 (04) :445-453
[9]   Worldwide prevalence of hypertension: a systematic review [J].
Kearney, PM ;
Whelton, M ;
Reynolds, K ;
Whelton, PK ;
He, J .
JOURNAL OF HYPERTENSION, 2004, 22 (01) :11-19
[10]  
LEAHY J, 2006, HEARTWISE, V16, P15